Another Case of Bell's Palsy Recurrence After Pfizer-BioNTech COVID-19 Vaccination
Twenty-seven months into the current pandemic and 18 months after vaccinations were made available, there are still relatively limited data on the incidence of recurrent Bell's Palsy after the administration of mRNA-based vaccines. The authors continue to believe that it is through rigorous rep...
Gespeichert in:
| Veröffentlicht in: | Curēus (Palo Alto, CA) CA), 2022-07, Vol.14 (7) |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 7 |
| container_start_page | |
| container_title | Curēus (Palo Alto, CA) |
| container_volume | 14 |
| creator | Zhang, Huailin Sanchez Gomez, Diana Repajic, Michael Liu, Antonio K |
| description | Twenty-seven months into the current pandemic and 18 months after vaccinations were made available, there are still relatively limited data on the incidence of recurrent Bell's Palsy after the administration of mRNA-based vaccines. The authors continue to believe that it is through rigorous reporting that the true incidence can be tabulated eventually. |
| doi_str_mv | 10.7759/cureus.27422 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9334026</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2696789377</sourcerecordid><originalsourceid>FETCH-LOGICAL-c243t-729f49c1a7a322051bb4080fa788f03633e2fc8a667e7fbfd1e37839f0bf25a33</originalsourceid><addsrcrecordid>eNpVkUtPAjEUhRujEYLs_AGTuHDjYB_DtN2YwPgiIUIIsm065VaGwBTbGRP89Y5CjK7uTe53zznJQeiS4B7nfXlrag916FGeUHqC2pSkIhZEJKd_9hbqhrDGGBPMKeb4HLVYXxKcStFGs0HpqhX4KNMBImejIWw21yGa6k3YRzNoDDyUBqKBrRpqaotP8PGwcC9zMKsomyxG9zGR0UIbU5S6Klx5gc5s8w3d4-yg18eHefYcjydPo2wwjg1NWBVzKm0iDdFcM0pxn-R5ggW2mgthMUsZA2qN0GnKgdvcLgkwLpi0OLe0rxnroLuD7q7Ot7A0UFZeb9TOF1vt98rpQv2_lMVKvbkPJRlLME0bgaujgHfvNYRKrV3tyyazoqlMuZCM84a6OVDGuxA82F8HgtV3CepQgvopgX0BICR4tA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2696789377</pqid></control><display><type>article</type><title>Another Case of Bell's Palsy Recurrence After Pfizer-BioNTech COVID-19 Vaccination</title><source>PubMed Central Open Access</source><source>PubMed Central</source><creator>Zhang, Huailin ; Sanchez Gomez, Diana ; Repajic, Michael ; Liu, Antonio K</creator><creatorcontrib>Zhang, Huailin ; Sanchez Gomez, Diana ; Repajic, Michael ; Liu, Antonio K</creatorcontrib><description>Twenty-seven months into the current pandemic and 18 months after vaccinations were made available, there are still relatively limited data on the incidence of recurrent Bell's Palsy after the administration of mRNA-based vaccines. The authors continue to believe that it is through rigorous reporting that the true incidence can be tabulated eventually.</description><identifier>ISSN: 2168-8184</identifier><identifier>EISSN: 2168-8184</identifier><identifier>DOI: 10.7759/cureus.27422</identifier><identifier>PMID: 35910698</identifier><language>eng</language><publisher>Palo Alto: Cureus Inc</publisher><subject>Allergy/Immunology ; Bell's palsy ; Case reports ; Coronaviruses ; COVID-19 vaccines ; Drug dosages ; Infectious Disease ; Medicine ; mRNA vaccines ; Neurology</subject><ispartof>Curēus (Palo Alto, CA), 2022-07, Vol.14 (7)</ispartof><rights>Copyright © 2022, Zhang et al. This work is published under https://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright © 2022, Zhang et al. 2022 Zhang et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c243t-729f49c1a7a322051bb4080fa788f03633e2fc8a667e7fbfd1e37839f0bf25a33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334026/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334026/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,728,781,785,886,27925,27926,53792,53794</link.rule.ids></links><search><creatorcontrib>Zhang, Huailin</creatorcontrib><creatorcontrib>Sanchez Gomez, Diana</creatorcontrib><creatorcontrib>Repajic, Michael</creatorcontrib><creatorcontrib>Liu, Antonio K</creatorcontrib><title>Another Case of Bell's Palsy Recurrence After Pfizer-BioNTech COVID-19 Vaccination</title><title>Curēus (Palo Alto, CA)</title><description>Twenty-seven months into the current pandemic and 18 months after vaccinations were made available, there are still relatively limited data on the incidence of recurrent Bell's Palsy after the administration of mRNA-based vaccines. The authors continue to believe that it is through rigorous reporting that the true incidence can be tabulated eventually.</description><subject>Allergy/Immunology</subject><subject>Bell's palsy</subject><subject>Case reports</subject><subject>Coronaviruses</subject><subject>COVID-19 vaccines</subject><subject>Drug dosages</subject><subject>Infectious Disease</subject><subject>Medicine</subject><subject>mRNA vaccines</subject><subject>Neurology</subject><issn>2168-8184</issn><issn>2168-8184</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNpVkUtPAjEUhRujEYLs_AGTuHDjYB_DtN2YwPgiIUIIsm065VaGwBTbGRP89Y5CjK7uTe53zznJQeiS4B7nfXlrag916FGeUHqC2pSkIhZEJKd_9hbqhrDGGBPMKeb4HLVYXxKcStFGs0HpqhX4KNMBImejIWw21yGa6k3YRzNoDDyUBqKBrRpqaotP8PGwcC9zMKsomyxG9zGR0UIbU5S6Klx5gc5s8w3d4-yg18eHefYcjydPo2wwjg1NWBVzKm0iDdFcM0pxn-R5ggW2mgthMUsZA2qN0GnKgdvcLgkwLpi0OLe0rxnroLuD7q7Ot7A0UFZeb9TOF1vt98rpQv2_lMVKvbkPJRlLME0bgaujgHfvNYRKrV3tyyazoqlMuZCM84a6OVDGuxA82F8HgtV3CepQgvopgX0BICR4tA</recordid><startdate>20220728</startdate><enddate>20220728</enddate><creator>Zhang, Huailin</creator><creator>Sanchez Gomez, Diana</creator><creator>Repajic, Michael</creator><creator>Liu, Antonio K</creator><general>Cureus Inc</general><general>Cureus</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope></search><sort><creationdate>20220728</creationdate><title>Another Case of Bell's Palsy Recurrence After Pfizer-BioNTech COVID-19 Vaccination</title><author>Zhang, Huailin ; Sanchez Gomez, Diana ; Repajic, Michael ; Liu, Antonio K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c243t-729f49c1a7a322051bb4080fa788f03633e2fc8a667e7fbfd1e37839f0bf25a33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Allergy/Immunology</topic><topic>Bell's palsy</topic><topic>Case reports</topic><topic>Coronaviruses</topic><topic>COVID-19 vaccines</topic><topic>Drug dosages</topic><topic>Infectious Disease</topic><topic>Medicine</topic><topic>mRNA vaccines</topic><topic>Neurology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhang, Huailin</creatorcontrib><creatorcontrib>Sanchez Gomez, Diana</creatorcontrib><creatorcontrib>Repajic, Michael</creatorcontrib><creatorcontrib>Liu, Antonio K</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Curēus (Palo Alto, CA)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhang, Huailin</au><au>Sanchez Gomez, Diana</au><au>Repajic, Michael</au><au>Liu, Antonio K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Another Case of Bell's Palsy Recurrence After Pfizer-BioNTech COVID-19 Vaccination</atitle><jtitle>Curēus (Palo Alto, CA)</jtitle><date>2022-07-28</date><risdate>2022</risdate><volume>14</volume><issue>7</issue><issn>2168-8184</issn><eissn>2168-8184</eissn><abstract>Twenty-seven months into the current pandemic and 18 months after vaccinations were made available, there are still relatively limited data on the incidence of recurrent Bell's Palsy after the administration of mRNA-based vaccines. The authors continue to believe that it is through rigorous reporting that the true incidence can be tabulated eventually.</abstract><cop>Palo Alto</cop><pub>Cureus Inc</pub><pmid>35910698</pmid><doi>10.7759/cureus.27422</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2168-8184 |
| ispartof | Curēus (Palo Alto, CA), 2022-07, Vol.14 (7) |
| issn | 2168-8184 2168-8184 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9334026 |
| source | PubMed Central Open Access; PubMed Central |
| subjects | Allergy/Immunology Bell's palsy Case reports Coronaviruses COVID-19 vaccines Drug dosages Infectious Disease Medicine mRNA vaccines Neurology |
| title | Another Case of Bell's Palsy Recurrence After Pfizer-BioNTech COVID-19 Vaccination |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T13%3A34%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Another%20Case%20of%20Bell's%20Palsy%20Recurrence%20After%20Pfizer-BioNTech%20COVID-19%20Vaccination&rft.jtitle=Cur%C4%93us%20(Palo%20Alto,%20CA)&rft.au=Zhang,%20Huailin&rft.date=2022-07-28&rft.volume=14&rft.issue=7&rft.issn=2168-8184&rft.eissn=2168-8184&rft_id=info:doi/10.7759/cureus.27422&rft_dat=%3Cproquest_pubme%3E2696789377%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2696789377&rft_id=info:pmid/35910698&rfr_iscdi=true |